2079-50-7

Usage

Uses

Used in Veterinary Medicine:
Ethanone, 1-[4-[2-(4-morpholinyl)ethoxy]phenyl]is used as an anthelmintic agent for treating parasitic worm infections in animals. It is effective in paralyzing and killing the parasites, facilitating their elimination by the host's immune system.
Used in Livestock Industry:
Ethanone, 1-[4-[2-(4-morpholinyl)ethoxy]phenyl]is used as a deworming agent for livestock. It helps maintain the health of animals by preventing and treating parasitic infections, ensuring optimal growth and productivity.
Availability:
Ethanone, 1-[4-[2-(4-morpholinyl)ethoxy]phenyl]is only available with a veterinarian's prescription for use in animals, ensuring proper administration and dosage to achieve the desired therapeutic effects while minimizing potential side effects.

Upstream product

• 3240-94-6 N-(2-chlorethyl)morpholine 
• 99-93-4 4-Hydroxyacetophenone 
• 622-40-2 2-(morpholin-4-yl)ethanol 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 3647-69-6 4-(2-chloroethyl)morpholine hydrochride 
• 110-91-8 morpholine 
• 55368-24-6 1-(4-(2-bromoethoxy)phenyl)ethan-1-one 

Downstream Products

• 266679-62-3 1-[4-(2-morpholin-4-yl-ethoxy)-phenyl]-ethanone oxime 
• 908289-07-6 C₁₇H₂₁NO₃S₂ 

Relevant academic research and scientific papers

4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease

Alzheimer's disease (AD) is a neurodegenerative disorder with multifactorial pathogenesis. Monoamine oxidase (MAO) and acetylcholinesterase enzymes (AChE) are potential targets for the treatment of AD. A total of 15 new propargyl containing 4,6-diphenylpy

Synthesis, characterization and antiamoebic activity of chalcones bearing N -substituted ethanamine tail

A series of chalcones (4-21) possessing N-substituted ethanamine were synthesized by the aldol condensation reaction of 1-(4-(2-substituted ethoxy)phenyl)ethanones with different aldehydes preceded by the reaction of 2-chloro N-substituted ethanamine hydr

PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to phenyl thiazole I and its therapeutic and prophylactic uses, wherein the variables Rz, Q, J, R1, R3, R5, R6, and R7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

Novel imidazole derivatives, their preparation and their use as medicaments

Novel imidazole compounds of the formula wherein the substituents are as defined in the application having antitumoral activity and use thereof.

Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neruotransmission

The present disclosure relates to dithiolethione derivatives as monoamino oxidase inhibitors, in particular MAO-B inhibitors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said dithiolethiones der

6-Aryl-4-methylsulfanyl-2H-pyran-2-one-3-carbonitriles as PPAR-γ activators

Various 6-aryl-3-cyano/methoxycarbonyl-4-methylsulfanyl-2H-pyran-2-ones have been synthesized as a potential substitute of 2,4-thiazolidinedione head group to express potent PPAR-γ transactivation response. Some of the screened compounds have shown promis

Synthesis, inhibitory activity towards human leukocyte elastase and molecular modelling studies of 1-carbamoyl-4-methyleneaminoxyazetidinones

Some monocyclic β-lactam derivatives of type 3 (MAOAs) in which the leaving group (LG) on the C(4) is a methyleneaminoxy moiety, were synthesised and tested in vitro and in vivo for their inhibitory activity towards human leukocyte elastase (HLE). Some compounds showed an appreciable in vitro inhibitory activity against this enzyme. Effects on the anti-HLE activity due to the nature of the substituents R and R1 present on their LG were observed and rationalised by means of molecular modelling techniques. The results of in vivo pharmacological tests indicated that MAOAs, while showing an inhibitory activity on the haemorrhage induced by HLE, did not exhibit any effects due to the R and R1 substituents. (C) 2000 Editions scientifiques et medicales Elsevier SAS.